Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Holding(s) in Company

29 Jun 2007 16:15

Ferrexpo PLC29 June 2007 TR - 1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Ferrexpo plc 2. Reason for the notification (please state Yes/No): An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: (No) An event changing the breakdown of voting rights: (No) Other (please specify): (No) 3. Full name of person(s) subject to the notification obligation (iii): Deutsche Bank AG 4. Full name of shareholder(s) (if different from 3): N/a 5. Date of the transaction and date on which the threshold is crossed or reached: 25 June 2007 6. Date on which issuer notified: 28 June 2007 7. Threshhold(s) that is/are crossed or reached: 4% 8 Notified details: A: Voting rights attached to shares Class/type of shares if possible Situation previous to theUsing the ISIN Code Triggering transaction No of No of Shares voting rights GB00B1XH2C03 25,767,196 25,767,196 Resulting situation after triggering the transaction: Class/type of shares No of shares No of voting rights % of voting rightsif possible usingthe ISIN Code Direct Direct Indirect Direct Indirect GB00B1XH2C03 23,894,179 23,894,179 N/a 3.94 - B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of votingFinancial date conversion rights that may be rightsInstrument period/date acquired if the instrument is Exercised/converted- - - - - Total (A+B) Number of voting rights % of voting rights23,894,179 3.94% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: N/a Proxy Voting 10. Name of proxy holder: N/a 11. Number of voting rights proxy holder will cease to hold: N/a 12. Date on which proxy holder will cease to hold voting rights: N/a 13. Additional information: None 14. Contact name: David Lindsay/Andrew Anderson 15. Contact telephone number: +00 44 207 545 8533/8532 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Climate Change Report
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary
31st Jul 202412:28 pmRNSInterim Results for six months ended 30 June 2024
31st Jul 20247:00 amRNSInterim Results for six months ended 30 June 2024
30th Jul 20245:50 pmRNSInterim Results Advisory
8th Jul 20247:00 amRNSProduction Report for 2Q 2024 and 1H 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.